These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1649974)

  • 1. Flow cytometric analysis of DNA content in focal nodular hyperplasia and hepatocellular carcinoma.
    Kopper L; Lapis K; Schaff Z; Mihalik R; Karácsony S; Szécsény A
    Neoplasma; 1991; 38(3):257-63. PubMed ID: 1649974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of cellular DNA content in human liver tumors.
    Kopper L; Lapis K; Schaff Z; Mihalik R
    Acta Biomed Ateneo Parmense; 1993; 64(5-6):165-9. PubMed ID: 7992554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative image cytometric DNA ploidy of liver cell dysplasia and hepatocellular carcinoma.
    Rubin EM; DeRose PB; Cohen C
    Mod Pathol; 1994 Aug; 7(6):677-80. PubMed ID: 7991527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative genomic hybridization. Synchronous occurrence of focal nodular hyperplasia and hepatocellular carcinoma in the same liver is not based on common chromosomal aberrations.
    Kellner U; Jacobsen A; Kellner A; Mantke R; Roessner A; Röcken C
    Am J Clin Pathol; 2003 Feb; 119(2):265-71. PubMed ID: 12579998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical studies on pathobiological characteristics of early hepatocellular carcinoma].
    Cong WM
    Zhonghua Wai Ke Za Zhi; 1991 Jun; 29(6):341-4, 396. PubMed ID: 1657551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric DNA analysis of hepatocellular carcinoma: preliminary report.
    Chen MF; Hwang TL; Tsao KC; Sun CF; Chen TJ
    Surgery; 1991 Apr; 109(4):455-8. PubMed ID: 1706892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathology and DNA cytophotometry of small hepatocellular carcinoma with a nodule-in-nodule appearance--evidence for stepwise progression of hepatocellular carcinoma.
    Rim KS; Sakamoto M; Watanabe H; Matsuno Y; Nakanishi Y; Mukai K; Hirohashi S
    Jpn J Clin Oncol; 1993 Feb; 23(1):26-33. PubMed ID: 8384672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor.
    Ruà S; Comino A; Fruttero A; Torchio P; Bouzari H; Taraglio S; Torchio B; Capussotti L
    Cancer; 1996 Sep; 78(6):1195-202. PubMed ID: 8826940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell biological evaluation of liver cell carcinoma, dysplasia and adenoma by tissue micro-array analysis.
    van Dekken H; Verhoef C; Wink J; van Marion R; Vissers KJ; Hop WC; de Man RA; IJzermans JN; van Eijck CH; Zondervan PE
    Acta Histochem; 2005; 107(3):161-71. PubMed ID: 16000213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric DNA analysis of ulcerative colitis using paraffin-embedded biopsy specimens: comparison with morphology and DNA analysis of fresh samples.
    Hartmann DP; Montgomery EA; Carr NJ; Gupta PK; Azumi N
    Am J Gastroenterol; 1995 Apr; 90(4):590-6. PubMed ID: 7717317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear ploidy of normal and neoplastic hepatocytes from woodchuck hepatitis virus-infected and uninfected woodchucks.
    Cullen JM; Linzey DW; Gebhard DH
    Hepatology; 1994 May; 19(5):1072-8. PubMed ID: 8175128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic implications of the ploidy pattern of the nuclear DNA in hepatocellular carcinomas].
    Omagari K; Imanishi T; Morikawa S; Nishihata S; Kamiya T; Hayashida K; Tanioka H; Murata I; Makiyama K; Ashihara K
    Gan No Rinsho; 1990 Feb; 36(2):121-6. PubMed ID: 2155330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometry DNA content and morphobiological characteristics in chronic and neoplastic human liver disease.
    Paradiso A; Barletta A; Prete F; Pellecchia A; Romagno D; Lucchese G; Benvestito V; Zito FA; Russo S; De Lena M
    Ital J Gastroenterol; 1995; 27(1):8-12. PubMed ID: 7795288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies.
    Nassar A; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2009 Sep; 37(9):629-35. PubMed ID: 19405109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Focal nodular hyperplasia and liver cell adenoma: operation or observation?].
    Ott R; Hohenberger W
    Zentralbl Chir; 1998; 123(2):145-53. PubMed ID: 9556887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation.
    Paradis V; Laurent A; Flejou JF; Vidaud M; Bedossa P
    Hepatology; 1997 Oct; 26(4):891-5. PubMed ID: 9328310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathobiology of human primary benign and malignant liver tumors].
    Schaff Z; Jeney A; Kopper L; Kovalszky I; Karácsonyi S; Szécsény A; Lapis K
    Morphol Igazsagugyi Orv Sz; 1990 Jan; 30(1):18-27. PubMed ID: 2407943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connective tissue content of fibrolamellar carcinoma and other human liver tumors.
    Sárosi I; Kiss A; Schaff Z; Lapis K
    Acta Microbiol Hung; 1991; 39(4):321-31. PubMed ID: 1668900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Feulgen-DNA cytofluorometry of the liver cell carcinomas].
    Kagawa K; Deguchi T; Fukui S; Tomimasu H; Okanoue T; Okuno T; Takino T; Kamachi M; Morotomi N; Fujimiya T
    Gan No Rinsho; 1984 Oct; 30(13):1643-50. PubMed ID: 6096590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric determination of DNA content in malignant and benign bone tumours.
    Heliö H; Karaharju E; Nordling S
    Cytometry; 1985 Mar; 6(2):165-71. PubMed ID: 3979218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.